{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T21:02:09Z","timestamp":1771275729237,"version":"3.50.1"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00203-025-04592-w","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T06:30:58Z","timestamp":1765261858000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Molecular links between tuberculosis and lung cancer: pathogenesis and therapeutic challenges"],"prefix":"10.1007","volume":"208","author":[{"given":"Francis","family":"Adu-Amankwaah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzzana Dickson","family":"Buabeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabella Sanette","family":"Agyekum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ndivhuwo","family":"Tshililo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucinda","family":"Baatjies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bienyameen","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"4592_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1177\/0218492320984881","volume":"29","author":"HW Abdelwahab","year":"2021","unstructured":"Abdelwahab HW, Elmaria MO, Abdelghany DA, Akl FMF, Shehta M, ELnagar RM, Farrag NS, Akl MF, Ehab A (2021) Screening of latent TB infection in patients with recently diagnosed bronchogenic carcinoma. Asian Cardiovasc Thorac Ann 29:208\u2013213. https:\/\/doi.org\/10.1177\/0218492320984881","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"4592_CR2","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/cei.13488","volume":"202","author":"A Ahmed","year":"2020","unstructured":"Ahmed A, Vyakarnam A (2020) Emerging patterns of regulatory T cell function in tuberculosis. Clin Exp Immunol 202:273\u2013287. https:\/\/doi.org\/10.1111\/cei.13488","journal-title":"Clin Exp Immunol"},{"key":"4592_CR3","unstructured":"American cancer Society (2024) global-cancer-facts-and-figures-2024. 5:1\u201348"},{"key":"4592_CR4","doi-asserted-by":"publisher","unstructured":"Ashenafi S, Brighenti S (2022) Reinventing the human tuberculosis (TB) granuloma: learning from the cancer field. Front Immunol 13. https:\/\/doi.org\/10.3389\/fimmu.2022.1059725","DOI":"10.3389\/fimmu.2022.1059725"},{"key":"4592_CR5","doi-asserted-by":"publisher","unstructured":"Bartolomeu-Gon\u00e7alves G, de Souza JM, Fernandes BT, Spoladori LFA, Correia GF, de Castro IM, Borges PHG, Silva-Rodrigues G, Tavares ER, Yamauchi LM, Pelisson M, Perugini MRE, Yamada-Ogatta SF (2024) Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches. Diseases 12. https:\/\/doi.org\/10.3390\/diseases12090202","DOI":"10.3390\/diseases12090202"},{"key":"4592_CR6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/ijms19040970","volume":"19","author":"A Basu","year":"2018","unstructured":"Basu A (2018) DNA Damage, mutagenesis and cancer. Int J Mol Sci 19:970. https:\/\/doi.org\/10.3390\/ijms19040970","journal-title":"Int J Mol Sci"},{"key":"4592_CR7","doi-asserted-by":"publisher","unstructured":"Bernardo J (2005) Tuberculosis. Immigrant medicine. Elsevier, pp 255\u2013271. https:\/\/doi.org\/10.1016\/B978-0-323-03454-8.50023-1","DOI":"10.1016\/B978-0-323-03454-8.50023-1"},{"key":"4592_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.4103\/2278-330X.96507","volume":"1","author":"M Bhatt","year":"2012","unstructured":"Bhatt M, Kant S, Bhaskar R (2012) Pulmonary tuberculosis as differential diagnosis of lung cancer. South Asian J Cancer 1:36\u201342. https:\/\/doi.org\/10.4103\/2278-330X.96507","journal-title":"South Asian J Cancer"},{"key":"4592_CR9","doi-asserted-by":"publisher","unstructured":"Bhowmik S, Mohanto NC, Sarker D, Sorove AA (2022) Incidence and Risk of Lung Cancer in Tuberculosis Patients, and Vice Versa: A Literature Review of the Last Decade. Biomed Res Int 2022. https:\/\/doi.org\/10.1155\/2022\/1702819","DOI":"10.1155\/2022\/1702819"},{"key":"4592_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176136","author":"TE Bickett","year":"2020","unstructured":"Bickett TE, Karam SD (2020) Tuberculosis\u2013cancer parallels in immune response regulation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21176136","journal-title":"Int J Mol Sci"},{"key":"4592_CR11","doi-asserted-by":"publisher","unstructured":"Boyles T, Berhanu RH, Gogela N, Gunter H, Lovelock T, Mphothulo N, Parker A, Rabie H, Richards L, Sinxadi P, Wattrus C, Moosa M-Y (2024) Management of drug-induced liver injury in people with HIV treated for tuberculosis: 2024 update. South Afr J HIV Med 25. https:\/\/doi.org\/10.4102\/sajhivmed.v25i1.1558","DOI":"10.4102\/sajhivmed.v25i1.1558"},{"key":"4592_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/2326-6066.CIR-21-0515","volume":"10","author":"N Budimir","year":"2022","unstructured":"Budimir N, Thomas GD, Dolina JS, Salek-Ardakani S (2022) Reversing T-cell exhaustion in cancer: lessons learned from PD-1\/PD-L1 immune checkpoint Blockade. Cancer Immunol Res 10:146\u2013153. https:\/\/doi.org\/10.1158\/2326-6066.CIR-21-0515","journal-title":"Cancer Immunol Res"},{"key":"4592_CR13","doi-asserted-by":"publisher","unstructured":"Cabrera-Sanchez J, Cuba V, Vega V, Van der Stuyft P, Otero L (2022) Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis. Eur Respir Rev 31. https:\/\/doi.org\/10.1183\/16000617.0025-2022","DOI":"10.1183\/16000617.0025-2022"},{"key":"4592_CR14","doi-asserted-by":"publisher","unstructured":"Carvalho SM, Beas JZ, Videira MAM, Saraiva LM (2022) Defenses of multidrug resistant pathogens against reactive nitrogen species produced in infected hosts. 85\u2013155. https:\/\/doi.org\/10.1016\/bs.ampbs.2022.02.001","DOI":"10.1016\/bs.ampbs.2022.02.001"},{"key":"4592_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/s41392-024-01907-z","volume":"9","author":"S Casacuberta-Serra","year":"2024","unstructured":"Casacuberta-Serra S, Gonz\u00e1lez-Larreategui \u00cd, Capit\u00e1n-Leo D, Soucek L (2024) MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer. Signal Transduct Target Ther 9:205. https:\/\/doi.org\/10.1038\/s41392-024-01907-z","journal-title":"Signal Transduct Target Ther"},{"key":"4592_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","volume":"8","author":"Z Chen","year":"2023","unstructured":"Chen Z, Han F, Du Y, Shi H, Zhou W (2023) Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8:70. https:\/\/doi.org\/10.1038\/s41392-023-01332-8","journal-title":"Signal Transduct Target Ther"},{"key":"4592_CR16","doi-asserted-by":"publisher","first-page":"e498","DOI":"10.1093\/oncolo\/oyad340","volume":"29","author":"H-W Chen","year":"2024","unstructured":"Chen H-W, Kuo Y-W, Chen C-Y, Chang C-H, Wang S-M, Chien Y-C, Lu W-C, Chen J-P, Chang C-Y, Wei Y-F, Chang S-C, Shu C-C, Wang J-Y, Liao W-Y, Wang H-C, Yu C-J (2024) Increased tuberculosis reactivation risk in patients receiving immune checkpoint Inhibitor-Based therapy. Oncologist 29:e498\u2013e506. https:\/\/doi.org\/10.1093\/oncolo\/oyad340","journal-title":"Oncologist"},{"key":"4592_CR18","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1093\/cid\/ciw838","volume":"64","author":"MP Cheng","year":"2017","unstructured":"Cheng MP, Chakra CNA, Yansouni CP, Cnossen S, Shrier I, Menzies D, Greenaway C (2017) Risk of active tuberculosis in patients with cancer: A systematic review and metaanalysis. Clin Infect Dis 64:635\u2013644. https:\/\/doi.org\/10.1093\/cid\/ciw838","journal-title":"Clin Infect Dis"},{"key":"4592_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/jclinpath-2016-203868","volume":"70","author":"RS Dagaonkar","year":"2017","unstructured":"Dagaonkar RS, Choong CV, Asmat AB, Ahmed DBA, Chopra A, Lim AYH, Tai DYH, Kor AC, Goh SK, Abisheganaden J, Verma A (2017) Significance of coexistent granulomatous inflammation and lung cancer. J Clin Pathol 70:337\u2013341. https:\/\/doi.org\/10.1136\/jclinpath-2016-203868","journal-title":"J Clin Pathol"},{"key":"4592_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","volume":"41","author":"KE de Visser","year":"2023","unstructured":"de Visser KE, Joyce JA (2023) The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell 41:374\u2013403. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.016","journal-title":"Cancer Cell"},{"key":"4592_CR21","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.3892\/ol.2015.3786","volume":"10","author":"Q-M Dong","year":"2015","unstructured":"Dong Q-M, Ling C, Chen X, Zhao LI (2015) Inhibition of tumor necrosis factor-\u03b1 enhances apoptosis induced by nuclear factor-\u03baB Inhibition in leukemia cells. Oncol Lett 10:3793\u20133798. https:\/\/doi.org\/10.3892\/ol.2015.3786","journal-title":"Oncol Lett"},{"key":"4592_CR23","doi-asserted-by":"publisher","first-page":"7905","DOI":"10.1007\/s00210-024-03135-2","volume":"397","author":"W Fang","year":"2024","unstructured":"Fang W, Sun W, Fang, Weijin, Zhang J, Wang C (2024) Clinical features, treatment, and outcome of pembrolizumab induced cholangitis. Naunyn Schmiedebergs Arch Pharmacol 397:7905\u20137912. https:\/\/doi.org\/10.1007\/s00210-024-03135-2","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"4592_CR22","doi-asserted-by":"publisher","unstructured":"Fang C, He X, Tang F, Wang Z, Pan C, Zhang Q, Wu J, Wang Q, Liu D, Zhang Y (2025) Where lung cancer and tuberculosis intersect: recent advances. Front Immunol 16. https:\/\/doi.org\/10.3389\/fimmu.2025.1561719","DOI":"10.3389\/fimmu.2025.1561719"},{"key":"4592_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158332","author":"M Fol","year":"2021","unstructured":"Fol M, Kozi\u0144ski P, Kulesza J, Bia\u0142ecki P, Druszczy\u0144ska M (2021) Dual nature of relationship between mycobacteria and cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22158332","journal-title":"Int J Mol Sci"},{"key":"4592_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3390\/ijms26010018","volume":"26","author":"C Franco","year":"2024","unstructured":"Franco C, Rezzani R (2024) Methods and models for studying Mycobacterium tuberculosis in respiratory infections. Int J Mol Sci 26:18. https:\/\/doi.org\/10.3390\/ijms26010018","journal-title":"Int J Mol Sci"},{"key":"4592_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26010018","author":"C Franco","year":"2025","unstructured":"Franco C, Rezzani R (2025) Methods and models for studying Mycobacterium tuberculosis in respiratory infections. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms26010018","journal-title":"Int J Mol Sci"},{"key":"4592_CR27","unstructured":"Global tuberculosisreport (2024) 2024 Global tuberculosis report"},{"key":"4592_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.gde.2009.11.004","volume":"20","author":"SI Grivennikov","year":"2010","unstructured":"Grivennikov SI, Karin M (2010) Inflammation and oncogenesis: a vicious connection. Curr Opin Genet Dev 20:65\u201371. https:\/\/doi.org\/10.1016\/j.gde.2009.11.004","journal-title":"Curr Opin Genet Dev"},{"key":"4592_CR29","doi-asserted-by":"publisher","first-page":"108557","DOI":"10.1016\/j.cclet.2023.108557","volume":"35","author":"L Guo","year":"2024","unstructured":"Guo L, Ding J, Zhou W (2024) Harnessing bacteria for tumor therapy: current advances and challenges. Chin Chem Lett 35:108557. https:\/\/doi.org\/10.1016\/j.cclet.2023.108557","journal-title":"Chin Chem Lett"},{"key":"4592_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cellimm.2015.11.007","volume":"300","author":"PK Gupta","year":"2016","unstructured":"Gupta PK, Tripathi D, Kulkarni S, Rajan MGR (2016) Mycobacterium tuberculosis H37Rv infected THP-1 cells induce epithelial mesenchymal transition (EMT) in lung adenocarcinoma epithelial cell line (A549). Cell Immunol 300:33\u201340. https:\/\/doi.org\/10.1016\/j.cellimm.2015.11.007","journal-title":"Cell Immunol"},{"key":"4592_CR32","volume-title":"The hallmarks of cancer review evolve progressively from normalcy","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer review evolve progressively from normalcy. via a series of pre, Cell"},{"key":"4592_CR31","doi-asserted-by":"publisher","unstructured":"Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell https:\/\/doi.org\/10.1016\/j.cell.2011.02.013","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"4592_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.lungcan.2018.05.030","volume":"122","author":"JC Ho","year":"2018","unstructured":"Ho JC, Leung C-C (2018) Management of co-existent tuberculosis and lung cancer. Lung Cancer 122:83\u201387","journal-title":"Lung Cancer"},{"key":"4592_CR35","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RMGJ Houben","year":"2016","unstructured":"Houben RMGJ, Dodd PJ (2016) The global burden of latent tuberculosis infection: A Re-estimation using mathematical modelling. PLoS Med 13:e1002152. https:\/\/doi.org\/10.1371\/journal.pmed.1002152","journal-title":"PLoS Med"},{"key":"4592_CR37","doi-asserted-by":"publisher","first-page":"e482","DOI":"10.1016\/S2666-5247(22)00087-8","volume":"3","author":"Z Huang","year":"2022","unstructured":"Huang Z, LaCourse SM, Kay AW, Stern J, Escudero JN, Youngquist BM, Zheng W, Vambe D, Dlamini M, Mtetwa G, Cranmer LM, Njuguna I, Wamalwa DC, Maleche-Obimbo E, Catanzaro DG, Lyon CJ, John-Stewart G, DiNardo A, Mandalakas AM, Ning B, Hu TY (2022a) CRISPR detection of Circulating cell-free Mycobacterium tuberculosis DNA in adults and children, including children with HIV: a molecular diagnostics study. Lancet Microbe 3:e482\u2013e492. https:\/\/doi.org\/10.1016\/S2666-5247(22)00087-8","journal-title":"Lancet Microbe"},{"key":"4592_CR38","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1002\/mco2.144","volume":"3","author":"Z Huang","year":"2022","unstructured":"Huang Z, Zhang Z, Zhou C, Liu L, Huang C (2022b) Epithelial-mesenchymal transition: the history, regulatory mechanism, and cancer therapeutic opportunities. MedComm (Beijing) 3:e144. https:\/\/doi.org\/10.1002\/mco2.144","journal-title":"MedComm (Beijing)"},{"key":"4592_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41392-025-02243-6","volume":"10","author":"Q Huang","year":"2025","unstructured":"Huang Q, Li Y, Huang Y, Wu J, Bao W, Xue C, Li X, Dong S, Dong Z, Hu S (2025) Advances in molecular pathology and therapy of non-small cell lung cancer. Signal Transduct Target Ther 10:186. https:\/\/doi.org\/10.1038\/s41392-025-02243-6","journal-title":"Signal Transduct Target Ther"},{"key":"4592_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.14745\/ccdr.v43i34a01","volume":"43","author":"S Kiazyk","year":"2017","unstructured":"Kiazyk S, Ball T (2017) Latent tuberculosis infection: an overview. Can Commun Dis Rep 43:62\u201366. https:\/\/doi.org\/10.14745\/ccdr.v43i34a01","journal-title":"Can Commun Dis Rep"},{"key":"4592_CR40","doi-asserted-by":"publisher","first-page":"138","DOI":"10.3348\/kjr.2001.2.3.138","volume":"2","author":"Y Kim","year":"2001","unstructured":"Kim Y, Il, Goo JM, Kim HY, Song JW, Im J-G (2001) Coexisting bronchogenic carcinoma and pulmonary tuberculosis in the same lobe: radiologic findings and clinical significance. Korean J Radiol 2:138. https:\/\/doi.org\/10.3348\/kjr.2001.2.3.138","journal-title":"Korean J Radiol"},{"key":"4592_CR41","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1002\/cncr.35128","volume":"130","author":"TB Kratzer","year":"2024","unstructured":"Kratzer TB, Bandi P, Freedman ND, Smith RA, Travis WD, Jemal A, Siegel RL (2024) Lung cancer statistics, 2023. Cancer 130:1330\u20131348. https:\/\/doi.org\/10.1002\/cncr.35128","journal-title":"Cancer"},{"key":"4592_CR42","doi-asserted-by":"publisher","unstructured":"Krylova YS, Kudriashov GG, Tochilnikov GV, Vinogradova TI, Dokhov MA, Yablonskii PK (2024) Biological model of lung cancer combination and tuberculosis: development for preclinical study of rational combinations of targeted antitumor and antituberculosis therapy. Molekulyarnaya Meditsina (Molecular medicine) 23\u201328. https:\/\/doi.org\/10.29296\/24999490-2024-02-04","DOI":"10.29296\/24999490-2024-02-04"},{"key":"4592_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12094-024-03590-6","volume":"27","author":"RMR Kumar","year":"2024","unstructured":"Kumar RMR (2024) Exosomal micrornas: impact on cancer detection, treatment, and monitoring. Clin Transl Oncol 27:83\u201394. https:\/\/doi.org\/10.1007\/s12094-024-03590-6","journal-title":"Clin Transl Oncol"},{"key":"4592_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12094-024-03590-6","volume":"27","author":"RMR Kumar","year":"2025","unstructured":"Kumar RMR (2025) Exosomal micrornas: impact on cancer detection, treatment, and monitoring. Clin Transl Oncol 27:83\u201394","journal-title":"Clin Transl Oncol"},{"key":"4592_CR45","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12885-020-06891-5","volume":"20","author":"CY Leung","year":"2020","unstructured":"Leung CY, Huang H-L, Rahman MM, Nomura S, Krull Abe S, Saito E, Shibuya K (2020) Cancer incidence attributable to tuberculosis in 2015: global, regional, and National estimates. BMC Cancer 20:412","journal-title":"BMC Cancer"},{"key":"4592_CR46","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","volume":"12","author":"M Li","year":"2022","unstructured":"Li M, He L, Zhu J, Zhang P, Liang S (2022) Targeting tumor-associated macrophages for cancer treatment. Cell Biosci 12:85. https:\/\/doi.org\/10.1186\/s13578-022-00823-5","journal-title":"Cell Biosci"},{"key":"4592_CR47","doi-asserted-by":"crossref","unstructured":"Liang W, Tao J, Cheng C, Sun H, Ye Z, Wu S, Guo Y, Zhang J, Chen Q, Liu D (2024) A clinically effective model based on cell-free DNA methylation and low-dose CT for risk stratification of pulmonary nodules. Cell Rep Med 5","DOI":"10.1016\/j.xcrm.2024.101750"},{"key":"4592_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11010-019-03522-x","volume":"457","author":"J Lin","year":"2019","unstructured":"Lin J, Chang Q, Dai X, Liu D, Jiang Y, Dai Y (2019) Early secreted antigenic target of 6-kDa of Mycobacterium tuberculosis promotes caspase-9\/caspase-3-mediated apoptosis in macrophages. Mol Cell Biochem 457:179\u2013189. https:\/\/doi.org\/10.1007\/s11010-019-03522-x","journal-title":"Mol Cell Biochem"},{"key":"4592_CR49","doi-asserted-by":"publisher","first-page":"20002","DOI":"10.1038\/s41598-022-16744-9","volume":"12","author":"B Liu","year":"2022","unstructured":"Liu B, Du H, Zhang J, Jiang J, Zhang X, He F, Niu B (2022) Developing a new sepsis screening tool based on lymphocyte count, international normalized ratio and procalcitonin (LIP score). Sci Rep 12:20002. https:\/\/doi.org\/10.1038\/s41598-022-16744-9","journal-title":"Sci Rep"},{"key":"4592_CR50","doi-asserted-by":"publisher","first-page":"100146","DOI":"10.1016\/j.cellin.2024.100146","volume":"3","author":"R Liu","year":"2024","unstructured":"Liu R, Li H-F, Li S (2024) PD-1-mediated Inhibition of T cell activation: mechanisms and strategies for cancer combination immunotherapy. Cell Insight 3:100146. https:\/\/doi.org\/10.1016\/j.cellin.2024.100146","journal-title":"Cell Insight"},{"key":"4592_CR51","doi-asserted-by":"publisher","first-page":"e0278661","DOI":"10.1371\/journal.pone.0278661","volume":"17","author":"P Luczynski","year":"2022","unstructured":"Luczynski P, Poulin P, Romanowski K, Johnston JC (2022) Tuberculosis and risk of cancer: A systematic review and meta-analysis. PLoS ONE 17:e0278661. https:\/\/doi.org\/10.1371\/journal.pone.0278661","journal-title":"PLoS ONE"},{"key":"4592_CR53","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s10637-024-01452-0","volume":"42","author":"P Luo","year":"2024","unstructured":"Luo P, Guo Y, He Y, Wang C (2024) Clinical characteristics, treatment and outcome of pembrolizumab-induced acute pancreatitis. Invest New Drugs 42:369\u2013375. https:\/\/doi.org\/10.1007\/s10637-024-01452-0","journal-title":"Invest New Drugs"},{"key":"4592_CR52","doi-asserted-by":"publisher","unstructured":"Luo J, Li X, Zhang L, Deng M, Zhao J, Zhang J, Tang W, Guo Q, Wang L (2025) 5-deoxy-rutaecarpine protects against LPS-induced acute lung injury via inhibiting NLRP3 inflammasome-related inflammation. Front Pharmacol 16. https:\/\/doi.org\/10.3389\/fphar.2025.1522146","DOI":"10.3389\/fphar.2025.1522146"},{"key":"4592_CR54","doi-asserted-by":"publisher","unstructured":"Ma J, Wu Y, Ma L, Yang X, Zhang T, Song G, Li T, Gao K, Shen X, Lin J, Chen Y, Liu X, Fu Y, Gu X, Chen Z, Jiang S, Rao D, Pan J, Zhang S, Zhou J, Huang C, Shi S, Fan J, Guo G, Zhang X, Gao Q (2024a) A blueprint for tumor-infiltrating B cells across human cancers. Sci (1979) 384. https:\/\/doi.org\/10.1126\/science.adj4857","DOI":"10.1126\/science.adj4857"},{"key":"4592_CR55","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41392-024-02021-w","volume":"9","author":"L Ma","year":"2024","unstructured":"Ma L, Guo H, Zhao Y, Liu Z, Wang C, Bu J, Sun T, Wei J (2024b) Liquid biopsy in cancer: current status, challenges and future prospects. Signal Transduct Target Ther 9:336. https:\/\/doi.org\/10.1038\/s41392-024-02021-w","journal-title":"Signal Transduct Target Ther"},{"key":"4592_CR56","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/21505594.2020.1726561","volume":"11","author":"A Madhvi","year":"2020","unstructured":"Madhvi A, Mishra H, Chegou NN, Tromp G, Van Heerden CJ, Pietersen RD, Leisching G, Baker B (2020) Distinct host-immune response toward species related intracellular mycobacterial killing: A transcriptomic study. Virulence 11:170\u2013182. https:\/\/doi.org\/10.1080\/21505594.2020.1726561","journal-title":"Virulence"},{"key":"4592_CR57","doi-asserted-by":"publisher","first-page":"151558","DOI":"10.1016\/j.ijmm.2022.151558","volume":"312","author":"AA Malik","year":"2022","unstructured":"Malik AA, Sheikh JA, Ehtesham NZ, Hira S, Hasnain SE (2022) Can Mycobacterium tuberculosis infection lead to cancer? Call for a paradigm shift in Understanding TB and cancer. Int J Med Microbiol 312:151558. https:\/\/doi.org\/10.1016\/j.ijmm.2022.151558","journal-title":"Int J Med Microbiol"},{"key":"4592_CR58","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1089\/ars.2012.5149","volume":"20","author":"M Mittal","year":"2014","unstructured":"Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20:1126\u20131167. https:\/\/doi.org\/10.1089\/ars.2012.5149","journal-title":"Antioxid Redox Signal"},{"key":"4592_CR59","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1093\/cid\/ciad373","volume":"77","author":"SM Moon","year":"2023","unstructured":"Moon SM, Choi H, Kim SH, Kang HK, Park DW, Jung JH, Han K, Shin DW, Lee H (2023) Increased lung cancer risk and associated risk factors in tuberculosis survivors: a Korean population-based study. Clin Infect Dis 77:1329\u20131339. https:\/\/doi.org\/10.1093\/cid\/ciad373","journal-title":"Clin Infect Dis"},{"key":"4592_CR60","doi-asserted-by":"publisher","first-page":"20180124","DOI":"10.1259\/bjrcr.20180124","volume":"5","author":"K Morikawa","year":"2019","unstructured":"Morikawa K, Misumi S, Fukuda T (2019) A case of pulmonary tuberculosis with multiple nodules mimicking lung metastases. BJR Case Rep 5:20180124. https:\/\/doi.org\/10.1259\/bjrcr.20180124","journal-title":"BJR Case Rep"},{"key":"4592_CR61","doi-asserted-by":"publisher","first-page":"1445678","DOI":"10.3389\/or.2024.1445678","volume":"18","author":"M Mortezazadeh","year":"2024","unstructured":"Mortezazadeh M, Karimi M, Esfandbod M, Mofidi A, Hemmati N, Kashani M, Shirsalimi N, Mahmoudi S, Kamali Yazdi ST, E (2024) Investigation of the prevalence of latent tuberculosis in cancer patients compared to non-cancer patients: a case-control study. Oncol Rev 18:1445678. https:\/\/doi.org\/10.3389\/or.2024.1445678","journal-title":"Oncol Rev"},{"key":"4592_CR62","doi-asserted-by":"publisher","first-page":"2715","DOI":"10.31557\/APJCP.2020.21.9.2715","volume":"21","author":"S Nanthanangkul","year":"2020","unstructured":"Nanthanangkul S, Promthet S, Suwanrungruang K, Santong C, Vatanasapt P (2020) Incidence of and risk factors for tuberculosis among cancer patients in endemic area: a regional cohort study. Asian Pac J Cancer Prev 21:2715. https:\/\/doi.org\/10.31557\/APJCP.2020.21.9.2715","journal-title":"Asian Pac J Cancer Prev"},{"key":"4592_CR63","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/cells14070488","volume":"14","author":"A Nishida","year":"2025","unstructured":"Nishida A, Andoh A (2025) The role of inflammation in cancer: mechanisms of tumor Initiation, Progression, and metastasis. Cells 14:488. https:\/\/doi.org\/10.3390\/cells14070488","journal-title":"Cells"},{"key":"4592_CR64","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.3390\/cancers17132224","volume":"17","author":"KA Papavassiliou","year":"2025","unstructured":"Papavassiliou KA, Sofianidi AA, Spiliopoulos FG, Vassiliou AG, Papavassiliou AG (2025) New vistas in Mycobacterium tuberculosis infection and its association with lung cancer development. Cancers (Basel) 17:2224. https:\/\/doi.org\/10.3390\/cancers17132224","journal-title":"Cancers (Basel)"},{"key":"4592_CR65","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1513\/AnnalsATS.202010-1240OC","volume":"19","author":"HY Park","year":"2022","unstructured":"Park HY, Kang D, Shin SH, Choi H, Jang SH, Lee CH, Kim H, Kwon OJ, Rhee CK, Cho J (2022) Pulmonary tuberculosis and the incidence of lung cancer among patients with chronic obstructive pulmonary disease. Ann Am Thorac Soc 19:640\u2013648. https:\/\/doi.org\/10.1513\/AnnalsATS.202010-1240OC","journal-title":"Ann Am Thorac Soc"},{"key":"4592_CR66","doi-asserted-by":"publisher","unstructured":"Preda M, T\u0103nase BC, Zob DL, Gheorghe AS, Lungulescu CV, Dumitrescu EA, St\u0103nculeanu DL, Manolescu LSC, Popescu O, Ibraim E, Mahler B (2023) The bidirectional relationship between pulmonary tuberculosis and lung cancer. Int J Environ Res Public Health 20. https:\/\/doi.org\/10.3390\/ijerph20021282","DOI":"10.3390\/ijerph20021282"},{"key":"4592_CR67","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13027-022-00434-2","volume":"17","author":"Y Qin","year":"2022","unstructured":"Qin Y, Chen Y, Chen J, Xu K, Xu F, Shi J (2022) The relationship between previous pulmonary tuberculosis and risk of lung cancer in the future. Infect Agent Cancer 17:20. https:\/\/doi.org\/10.1186\/s13027-022-00434-2","journal-title":"Infect Agent Cancer"},{"key":"4592_CR68","doi-asserted-by":"publisher","first-page":"839","DOI":"10.3390\/pathogens12060839","volume":"12","author":"L Ramon-Luing","year":"2023","unstructured":"Ramon-Luing L, Palacios Y, Ruiz A, T\u00e9llez-Navarrete N, Chavez-Galan L (2023) Virulence factors of Mycobacterium tuberculosis as modulators of cell death mechanisms. Pathogens 12:839. https:\/\/doi.org\/10.3390\/pathogens12060839","journal-title":"Pathogens"},{"key":"4592_CR69","doi-asserted-by":"publisher","unstructured":"Rasool G, Khan AM, Mohy-Ud-Din R, Riaz M (2019) Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert \u00ae MTB\/RIF assay. Int J Immunopathol Pharmacol 33. https:\/\/doi.org\/10.1177\/2058738419827174","DOI":"10.1177\/2058738419827174"},{"key":"4592_CR70","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1177\/1947601911408889","volume":"2","author":"N Rivlin","year":"2011","unstructured":"Rivlin N, Brosh R, Oren M, Rotter V (2011) Mutations in the p53 tumor suppressor gene: important milestones at the various steps of tumorigenesis. Genes Cancer 2:466\u2013474. https:\/\/doi.org\/10.1177\/1947601911408889","journal-title":"Genes Cancer"},{"key":"4592_CR71","doi-asserted-by":"publisher","unstructured":"Saha D, Kanjilal P, Kaur M, Menon SV, Ashraf A, Kumar MR, Alqahtani T, Atteri S, Uti DE, Dhara B (2025) Transforming cancer diagnostics: the emergence of liquid biopsy and epigenetic markers. MedComm (Beijing) 6:e70388. https:\/\/doi.org\/10.1002\/mco2.70388","DOI":"10.1002\/mco2.70388"},{"key":"4592_CR72","doi-asserted-by":"publisher","first-page":"810","DOI":"10.7150\/jca.30300","volume":"10","author":"K Sapalidis","year":"2019","unstructured":"Sapalidis K, Sardeli C, Pavlidis E, Koimtzis G, Koulouris C, Michalopoulos N, Mantalovas S, Tsiouda T, Passos I, Kosmidis C, Giannakidis D, Surlin V, Katsaounis A, Alexandrou V, Amaniti A, Zarogoulidis P, Huang H, Li Q, Mogoanta S, Kesisoglou I (2019) Scar tissue to lung cancer; pathways and treatment. J Cancer 10:810\u2013818. https:\/\/doi.org\/10.7150\/jca.30300","journal-title":"J Cancer"},{"key":"4592_CR73","doi-asserted-by":"publisher","unstructured":"Sasindran SJ, Torrelles JB (2011) Mycobacterium tuberculosis infection and inflammation: what is beneficial for the host and for the bacterium? Front Microbiol 2. https:\/\/doi.org\/10.3389\/fmicb.2011.00002","DOI":"10.3389\/fmicb.2011.00002"},{"key":"4592_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jctube.2017.02.001","volume":"7","author":"KK Shah","year":"2017","unstructured":"Shah KK, Pritt BS, Alexander MP (2017) Histopathologic review of granulomatous inflammation. J Clin Tuberc Other Mycobact Dis 7:1\u201312. https:\/\/doi.org\/10.1016\/j.jctube.2017.02.001","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"4592_CR75","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.tim.2020.03.015","volume":"28","author":"R Sharan","year":"2020","unstructured":"Sharan R, Buc\u015fan AN, Ganatra S, Paiardini M, Mohan M, Mehra S, Khader SA, Kaushal D (2020) Chronic immune activation in TB\/HIV Co-infection. Trends Microbiol 28:619\u2013632. https:\/\/doi.org\/10.1016\/j.tim.2020.03.015","journal-title":"Trends Microbiol"},{"key":"4592_CR76","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.21037\/tlcr-21-524","volume":"10","author":"J Shi","year":"2021","unstructured":"Shi J, Li J, Wang Q, Cheng X, Du H, Han R, Li X, Zhao C, Gao G, He Y, Chen X, Su C, Ren S, Wu F, Zhang Z, Zhou C (2021a) The safety and efficacy of immunotherapy with anti-programmed cell death 1 monoclonal antibody for lung cancer complicated with Mycobacterium tuberculosis infection. Transl Lung Cancer Res 10:3929\u20133942. https:\/\/doi.org\/10.21037\/tlcr-21-524","journal-title":"Transl Lung Cancer Res"},{"key":"4592_CR77","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.21037\/tcr-21-1507","volume":"10","author":"S Shi","year":"2021","unstructured":"Shi S, Wang H, Liu X, Xiao J (2021b) Prediction of overall survival of non-small cell lung cancer with bone metastasis: an analysis of the Surveillance, epidemiology and end results (SEER) database. Transl Cancer Res 10:5191\u20135203. https:\/\/doi.org\/10.21037\/tcr-21-1507","journal-title":"Transl Cancer Res"},{"key":"4592_CR78","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3390\/microorganisms13051032","volume":"13","author":"ML Silva","year":"2025","unstructured":"Silva ML, Os\u00f3rio NS, Saraiva M (2025) Immunoinformatics predictions on variable Mycobacterium tuberculosis lineage 6 T cell epitopes and HLA interactions in West Africa. Microorganisms 13:1032. https:\/\/doi.org\/10.3390\/microorganisms13051032","journal-title":"Microorganisms"},{"key":"4592_CR79","doi-asserted-by":"publisher","unstructured":"Thomas SS, Abhinand K, Menon AM, Nair BG, Kumar GB, Arun KB, Edison LK, Madhavan A (2024) Epigenetic mechanisms induced by Mycobacterium tuberculosis to promote its survival in the host. Int J Mol Sci 25. https:\/\/doi.org\/10.3390\/ijms252111801","DOI":"10.3390\/ijms252111801"},{"key":"4592_CR80","doi-asserted-by":"publisher","first-page":"1508345","DOI":"10.3389\/fmicb.2024.1508345","volume":"15","author":"D Tripathi","year":"2024","unstructured":"Tripathi D, Garg R (2024) Editorial: Host-pathogen crosstalk: implications in host cellular processes by intracellular pathogens. Front Microbiol 15:1508345. https:\/\/doi.org\/10.3389\/fmicb.2024.1508345","journal-title":"Front Microbiol"},{"key":"4592_CR81","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.3390\/ijms25116255","volume":"25","author":"A Vu","year":"2024","unstructured":"Vu A, Glassman I, Campbell G, Yeganyan S, Nguyen J, Shin A, Venketaraman V (2024) Host cell death and modulation of immune response against Mycobacterium tuberculosis infection. Int J Mol Sci 25:6255. https:\/\/doi.org\/10.3390\/ijms25116255","journal-title":"Int J Mol Sci"},{"key":"4592_CR82","doi-asserted-by":"publisher","unstructured":"Wang H, Li B, Sun Y, Ma Q, Feng Y, Jia Y, Wang W, Su M, Liu X, Shu B, Zheng J, Sang S, Yan Y, Wu Y, Zhang Y, Gao Q, Li P, Wang J, Ma F, Li X, Yan D, Wang D, Zou X, Liao Y (2024) NIR-II AIE Luminogen\u2010Based Erythrocyte\u2010Like nanoparticles with Granuloma\u2010Targeting and Self\u2010Oxygenation characteristics for combined phototherapy of tuberculosis. Adv Mater 36. https:\/\/doi.org\/10.1002\/adma.202406143","DOI":"10.1002\/adma.202406143"},{"key":"4592_CR83","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.trecan.2022.12.008","volume":"9","author":"MB Watowich","year":"2023","unstructured":"Watowich MB, Gilbert MR, Larion M (2023) T cell exhaustion in malignant gliomas. Trends Cancer 9:270\u2013292. https:\/\/doi.org\/10.1016\/j.trecan.2022.12.008","journal-title":"Trends Cancer"},{"key":"4592_CR84","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/TACG.S457395","volume":"17","author":"W Wodelo","year":"2024","unstructured":"Wodelo W, Wampande EM, Andama A, Kateete DP, Ssekatawa K (2024) Polymorphisms in immune genes and their association with tuberculosis susceptibility: an analysis of the African population. Appl Clin Genet 17:33\u201346. https:\/\/doi.org\/10.2147\/TACG.S457395","journal-title":"Appl Clin Genet"},{"key":"4592_CR85","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1128\/CMR.00011-10","volume":"23","author":"LE Wroblewski","year":"2010","unstructured":"Wroblewski LE, Peek RM, Wilson KT (2010) Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev 23:713\u2013739. https:\/\/doi.org\/10.1128\/CMR.00011-10","journal-title":"Clin Microbiol Rev"},{"key":"4592_CR86","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1016\/j.cell.2024.02.005","volume":"187","author":"Y Wu","year":"2024","unstructured":"Wu Y, Ma J, Yang X, Nan F, Zhang T, Ji S, Rao D, Feng H, Gao K, Gu X, Jiang S, Song G, Pan J, Zhang M, Xu Y, Zhang S, Fan Y, Wang X, Zhou J, Yang L, Fan J, Zhang X, Gao Q (2024a) Neutrophil profiling illuminates anti-tumor antigen-presenting potency. Cell 187:1422\u20131439e24. https:\/\/doi.org\/10.1016\/j.cell.2024.02.005","journal-title":"Cell"},{"key":"4592_CR87","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1158\/2159-8290.CD-23-1509","volume":"14","author":"Y Wu","year":"2024","unstructured":"Wu Y, Zou Q, Jiang P, Gao Q (2024b) Tumor-Host cometabolism collaborates to shape cancer immunity. Cancer Discov 14:653\u2013657. https:\/\/doi.org\/10.1158\/2159-8290.CD-23-1509","journal-title":"Cancer Discov"},{"key":"4592_CR88","doi-asserted-by":"publisher","first-page":"644150","DOI":"10.3389\/fonc.2021.644150","volume":"11","author":"Y Xiang","year":"2021","unstructured":"Xiang Y, Huang C, He Y, Zhang Q (2021) Cancer or tuberculosis: A comprehensive review of the clinical and imaging features in diagnosis of the confusing mass. Front Oncol 11:644150. https:\/\/doi.org\/10.3389\/fonc.2021.644150","journal-title":"Front Oncol"},{"key":"4592_CR89","doi-asserted-by":"publisher","first-page":"1467509","DOI":"10.3389\/fpubh.2025.1467509","volume":"13","author":"S Xie","year":"2025","unstructured":"Xie S, Xiao H, Xu L, Zhang F, Luo M (2025) Decadal trends and regional disparities in tuberculosis burden: a comprehensive analysis of global, African, and Southeast Asian data from the GBD 1990\u20132021. Front Public Health 13:1467509. https:\/\/doi.org\/10.3389\/fpubh.2025.1467509","journal-title":"Front Public Health"},{"key":"4592_CR90","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.2174\/1386207326666230823093958","volume":"27","author":"Q Xing","year":"2024","unstructured":"Xing Q, Liu X, Liu Z, Yan Q, Hu Y, Li W, Peng K (2024) Elucidating the mechanism of Buyanghuanwu Decoction acting on pulmonary fibrosis based on network Pharmacology and animal studies. Comb Chem High Throughput Screen 27:1046\u20131055. https:\/\/doi.org\/10.2174\/1386207326666230823093958","journal-title":"Comb Chem High Throughput Screen"},{"key":"4592_CR91","doi-asserted-by":"publisher","first-page":"4012","DOI":"10.21037\/tlcr-21-465","volume":"10","author":"K Xiong","year":"2021","unstructured":"Xiong K, Sun W, He Y, Fan L (2021) Advances in molecular mechanisms of interaction between Mycobacterium tuberculosis and lung cancer: a narrative review. Transl Lung Cancer Res 10:4012\u20134026. https:\/\/doi.org\/10.21037\/tlcr-21-465","journal-title":"Transl Lung Cancer Res"},{"key":"4592_CR92","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.12659\/msm.897638","volume":"22","author":"F Yakar","year":"2016","unstructured":"Yakar F, Yakar A, B\u00fcy\u00fckp\u0131narba\u015f\u0131l\u0131 N, Erelel M (2016) Does every necrotizing granulomatous inflammation identified by NSCLC resection material require treatment? Med Sci Monit 22:1218\u20131222. https:\/\/doi.org\/10.12659\/msm.897638","journal-title":"Med Sci Monit"},{"key":"4592_CR93","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/med4.58","volume":"2","author":"L Yang","year":"2024","unstructured":"Yang L, Ye Z, Li L, Zhuang L, Guan J, Gong W (2024) Visualization analysis of research progress and trends in coexistence of lung cancer and pulmonary tuberculosis using bibliometrics. Med Adv 2:144\u2013164","journal-title":"Med Adv"},{"key":"4592_CR96","doi-asserted-by":"publisher","first-page":"114046","DOI":"10.1016\/j.biopha.2022.114046","volume":"157","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Liang F, Zhang D, Qi S, Liu Y (2023) Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: an emerging field of study to diagnostic and therapeutic purposes. Biomed Pharmacother 157:114046. https:\/\/doi.org\/10.1016\/j.biopha.2022.114046","journal-title":"Biomed Pharmacother"},{"key":"4592_CR95","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-024-01848-7","volume":"9","author":"S Zhang","year":"2024","unstructured":"Zhang S, Xiao X, Yi Y, Wang X, Zhu L, Shen Y, Lin D, Wu C (2024) Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets. Signal Transduct Target Ther 9:149. https:\/\/doi.org\/10.1038\/s41392-024-01848-7","journal-title":"Signal Transduct Target Ther"},{"key":"4592_CR94","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12885-024-13350-y","volume":"25","author":"F Zhang","year":"2025","unstructured":"Zhang F, Qi F, Han Y, Yang H, Wang Y, Wang G, Dong Y, Li H, Gao Y, Zhang H (2025) Clinical and imaging features of co-existent pulmonary tuberculosis and lung cancer: a population-based matching study in China. BMC Cancer 25:89. https:\/\/doi.org\/10.1186\/s12885-024-13350-y","journal-title":"BMC Cancer"},{"key":"4592_CR97","doi-asserted-by":"publisher","first-page":"e70213","DOI":"10.1002\/cnr2.70213","volume":"8","author":"W Zhou","year":"2025","unstructured":"Zhou W, Lu H, Lin J, Zhu J, Liang J, Xie Y, Hu J, Su N (2025) Coexisting lung cancer and pulmonary tuberculosis: A comprehensive review from incidence to management. Cancer Rep (Hoboken) 8:e70213. https:\/\/doi.org\/10.1002\/cnr2.70213","journal-title":"Cancer Rep (Hoboken)"},{"key":"4592_CR98","doi-asserted-by":"publisher","unstructured":"Zhuang H-H, Chen Q-H, Wang W, Qu Q, Xu W-X, Hu Q, Wu X-L, Chen Y, Wan Q, Xu T-T, Long W-M, Luo Y, Zhang H-N, Qu J (2025) The efficacy of polymyxin B in treating stroke-associated pneumonia with carbapenem-resistant Gram-negative bacteria infections: a multicenter real-world study using propensity score matching. Front Pharmacol 16. https:\/\/doi.org\/10.3389\/fphar.2025.1413563","DOI":"10.3389\/fphar.2025.1413563"},{"key":"4592_CR99","doi-asserted-by":"publisher","unstructured":"Zifodya JS, Crothers K (2022) Tuberculosis, chronic obstructive lung Disease, and lung cancer: the Holey upper lobe trinity? Ann Am Thorac Soc https:\/\/doi.org\/10.1513\/AnnalsATS.202201-009ED","DOI":"10.1513\/AnnalsATS.202201-009ED"},{"key":"4592_CR100","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.3390\/cancers15102718","volume":"15","author":"DC Ziogas","year":"2023","unstructured":"Ziogas DC, Theocharopoulos C, Lialios P-P, Foteinou D, Koumprentziotis I-A, Xynos G, Gogas H (2023) Beyond CTLA-4 and PD-1 inhibition: novel immune checkpoint molecules for melanoma treatment. Cancers (Basel) 15:2718. https:\/\/doi.org\/10.3390\/cancers15102718","journal-title":"Cancers (Basel)"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04592-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04592-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04592-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:03:35Z","timestamp":1771272215000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04592-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["4592"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04592-w","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was not applicable in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"54"}}